Australia markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7500+0.0300 (+0.81%)
At close: 04:00PM EDT
3.7981 +0.05 (+1.28%)
After hours: 07:52PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
200,521
200,521
128,304
130,513
78,893
Cost of revenue
147,741
147,741
79,269
71,653
46,327
Gross profit
52,780
52,780
49,035
58,860
32,566
Operating expenses
Research development
187,170
187,170
193,000
112,899
64,152
Selling general and administrative
169,818
169,818
160,854
124,124
72,799
Total operating expenses
363,145
363,145
353,854
237,023
136,951
Operating income or loss
-310,365
-310,365
-304,819
-178,163
-104,385
Interest expense
14,343
14,343
14,690
12,530
267
Total other income/expenses net
6,549
6,549
5,261
-84,179
134,055
Income before tax
-318,159
-318,159
-314,248
-274,872
29,403
Income tax expense
-11,424
-11,424
0
-93,649
0
Income from continuing operations
-306,735
-306,735
-314,248
-181,223
29,403
Net income
-306,735
-306,735
-314,248
-181,223
29,403
Net income available to common shareholders
-306,735
-306,735
-314,248
-181,223
29,403
Basic EPS
-1.27
-1.21
-1.40
-0.89
0.18
Diluted EPS
-1.27
-1.21
-1.40
-0.89
0.17
Basic average shares
243,376
253,629
224,550
204,136
165,187
Diluted average shares
243,376
253,629
224,550
204,136
174,970